The UK’s medical cannabis sector has faced significant challenges in the year since the inaugural Cannabis Health Symposium, highlighting the need for greater collaboration across healthcare, industry and regulation. Most recently, the bankruptcy of Bedrocan’s Dutch operations has exposed vulnerabilities in medical cannabis supply chains and the difficulties families continue to face in accessing medicines […]
Read More
Building Safer, Stronger Medical Cannabis Services As the UK medical cannabis sector continues to develop, ensuring that clinical services are safe, effective and ready to deliver high-quality patient care is increasingly important. In our latest CIC Member Spotlight, we speak to Nitin Makadia MRCPharm, Director of Clinical Service Development & Clinical Safety from The Digital […]
Read More
Over the past six years, 4C Labs has established itself as one of the UK’s leading medical cannabis companies, building expertise across cultivation, importation, manufacturing and distribution. Now, with the launch of Emerald Health Clinic, a CQC-registered private medical clinic, the company is bringing that experience directly into patient care. For James Smith, Co-Founder, Chief […]
Read More
What does the UK medical cannabis sector need to do next? In the first episode of CIC Member Dalgety’s new podcast, CIC Treasurer and Board Member Nick Pateras joins the team for a discussion on the evolution of the UK medical cannabis industry, the role of domestic supply, the importance of education and transparency, and […]
Read More
The CIC team had the pleasure of visiting the RX Extraction team at their facility to showcase domestic cannabis manufacturing capabilities in the UK. Since launching in 2019, RX Extraction has been working towards a long-term vision of creating the infrastructure needed to manufacture high-quality cannabinoid medicines in the UK. Whilst much of the UK’s […]
Read More
When people talk about building a world-class medical cannabis industry in the UK, they often focus on policy, prescribing or patient access. Behind every prescription, however, is the quality and consistency of the medicine itself. For Cannabis Industry Council member Dalgety, that has been their mission from day one. Founded in 2019 and fully self-funded, […]
Read More
The CIC recently visited Glass Pharms’ UK cultivation facility to spotlight the company’s approach to producing consistent, pharmaceutical-grade medical cannabis in the UK and to better understand how domestic cultivation is helping shape the future of patient access. During the visit, the Glass Pharms team shared insight into the company’s growing processes, sustainability initiatives, and […]
Read More
New research published by Plantz and Cannavec.ai offers a fresh estimate of the size of the UK’s medical cannabis patient population, highlighting both the rapid growth of the sector and the continued lack of official nationwide patient reporting. According to the research, there are currently an estimated 60,000–75,000 active medical cannabis patients in the UK as […]
Read More
More than 70 international speakers and over 1000 delegates set to convene on London next month for policy debates, high-level networking and the 2026 Business of Cannabis Awards Cannabis Europa, the leading B2B conference for the European cannabis industry, today announced the full programme for its 2026 London edition. Taking place at The Barbican on […]
Read More
For UK patients prescribed medical cannabis, travel means navigating a legal grey area that can change dramatically depending on where you’re going. That’s exactly why the Cannabis Industry Council (CIC) has released its new guide, Travelling with Medical Cannabis: a practical, no-nonsense resource designed to help patients avoid common pitfalls and travel with confidence. Why […]
Read More